| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/05/2001 | US20010007022 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free N-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 07/05/2001 | US20010007019 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 07/05/2001 | US20010007017 For preventing AIDS or slowing down its progression |
| 07/05/2001 | US20010007015 Can be used as the basic structures (template molecules) for inhibiting and analysing amyloid formation and cytotoxicity in amyloid illnesses |
| 07/05/2001 | US20010006954 Synthetic DNA comprising a radiation responsive enhancer-promoter operatively linked to a polypeptide encoding region linked to a transcription terminating region; regulating gene expression and inhibiting tumor growth |
| 07/05/2001 | US20010006950 Include genetic vaccine components that confer the ability to direct an immune response so as to acheive an optimal response to vaccination |
| 07/05/2001 | US20010006948 So the gene is expressed; producing animal models for degenerative disc disease; genetically modified intervertebral disc cells; gene therapy |
| 07/05/2001 | US20010006944 Treating noninvasive fungus-induced rhinosinusitis by mucoadministering an antifungal agent; culturing noninvasive fungus from a mammalian mucus sample for antigen/antibody production; apparatus for collecting nasal mucus |
| 07/05/2001 | US20010006943 Protracted GLP-1 compositions |
| 07/05/2001 | US20010006942 Inducing an immune response against a chemokine receptor molecule by administering an immunogenic chemokine receptor polypeptide from an extracellular region of a chemokine receptor molecule; treating inflammation, multiple sclerosis |
| 07/05/2001 | US20010006939 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 07/05/2001 | US20010006816 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006815 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006814 Chemical modification |
| 07/05/2001 | US20010006801 Active ribozyme |
| 07/05/2001 | US20010006799 Histidine kinase polypeptides |
| 07/05/2001 | US20010006798 Novel FtsL |
| 07/05/2001 | US20010006797 Transfection cell with genetic vector |
| 07/05/2001 | US20010006796 Nucleic acids encoding variant human vectors |
| 07/05/2001 | US20010006792 Immunomodulatory properties |
| 07/05/2001 | US20010006788 Complexing glycoprotein with antibodies; medical diagnosis |
| 07/05/2001 | US20010006781 Cancer cells capable of tumorigenesis but incapable of infiltration and metastasis, process for preparing the same, and method for screening gene relating to metastasis by using the same |
| 07/05/2001 | US20010006778 Methods for identifying compounds that bind to a target |
| 07/05/2001 | US20010006683 Aqueous solution of troponin I, troponin T and troponin C in the form of an I-T-C ternary complex |
| 07/05/2001 | US20010006681 Chemokine inhibition of immunodeficiency virus |
| 07/05/2001 | US20010006642 Delivering antigens or biologically active polypeptides to a subject in need of same by administering to the subject a non-invasive or non-pathogenic bacterium which expresses the antigens or polypeptides |
| 07/05/2001 | US20010006641 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 |
| 07/05/2001 | US20010006640 Compounds and methods to inhibit or augment an inflammatory response |
| 07/05/2001 | US20010006639 Immunogenic peptides from the HPV E7 protein |
| 07/05/2001 | US20010006629 Recombinant adenoviral vector and methods of use |
| 07/05/2001 | US20010006620 Such a hirudin or oral thrombin inhibitor, by determining from the ratio of the dose given to the measured ecarin clotting time using a computer statistical analysis program |
| 07/05/2001 | CA2685457A1 Insecticidal proteins from bacillus thuringiensis |
| 07/05/2001 | CA2406668A1 High affinity tcr proteins and methods |
| 07/05/2001 | CA2397955A1 Method for pr-39 peptide mediated selective inhibition of i.kappa.b.alpha. degradation |
| 07/05/2001 | CA2397710A1 Streptococcus pyogenes virulence genes and proteins and their use |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2395926A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 07/05/2001 | CA2395779A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 07/05/2001 | CA2395715A1 Cytokine-like peptide |
| 07/05/2001 | CA2395454A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/05/2001 | CA2395442A1 Methods and materials relating to gene expression |
| 07/05/2001 | CA2395423A1 P. gingivalis antigenic composition |
| 07/05/2001 | CA2395382A1 Attenuated microorganisms for the treatment of infection |
| 07/05/2001 | CA2395335A1 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2395143A1 Novel cdnas encoding catenin-binding proteins with function in signalling and/or gene regulation |
| 07/05/2001 | CA2394880A1 Activation and inhibition of the immune system |
| 07/05/2001 | CA2394807A1 Gibberellin 2.beta.-hydroxylase genes of rice and uses thereof |
| 07/05/2001 | CA2394758A1 Histidine-containing copolymers enhance pharmaceutical agent delivery |
| 07/05/2001 | CA2394749A1 G protein-coupled receptors |
| 07/05/2001 | CA2394748A1 Optimized minigenes and peptides encoded thereby |
| 07/05/2001 | CA2394295A1 Antibodies against plasma cells |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/04/2001 | EP1113074A1 Actinobacillus pleuropneumoniae outer membrane protein and its use |
| 07/04/2001 | EP1113073A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 07/04/2001 | EP1113021A2 Polyamide-oligonucleotide derivatives, their production and use |
| 07/04/2001 | EP1112382A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 07/04/2001 | EP1112372A1 Alternatively targeted adenovirus |
| 07/04/2001 | EP1112370A1 Maize sina orthologue-1 and uses thereof |
| 07/04/2001 | EP1112369A2 REGULATION OF GENE EXPRESSION THROUGH MANIPULATION OF mRNA SPLICING AND ITS USES |
| 07/04/2001 | EP1112366A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 07/04/2001 | EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 07/04/2001 | EP1112364A2 Stomach polypeptide zsig28 |
| 07/04/2001 | EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 07/04/2001 | EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 07/04/2001 | EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 07/04/2001 | EP1112360A1 Ecdysone receptors and methods for their use |
| 07/04/2001 | EP1112359A2 Enhanced functional expression of g protein-coupled receptors |
| 07/04/2001 | EP1112358A2 Dna sequence encoding oncofetal ferritin protein |
| 07/04/2001 | EP1112357A1 Putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits, cacnglike2 (calcium channel gamma like 2) |
| 07/04/2001 | EP1112356A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancers |
| 07/04/2001 | EP1112355A1 Gene and protein libraries and methods relating thereto |
| 07/04/2001 | EP1112353A2 Recombinant protein production in urine |
| 07/04/2001 | EP1112286A1 Secreted proteins and polynucleotides encoding them |
| 07/04/2001 | EP1112285A1 Human chordin-related proteins and polynucleotides encoding them |
| 07/04/2001 | EP1112283A1 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins |
| 07/04/2001 | EP1112282A2 Canine growth hormone secretagogue receptor |
| 07/04/2001 | EP1112163A1 Bioriented polyethylene film with a high water vapor transmission rate |
| 07/04/2001 | EP1112096A1 Collagenous tissue compositions |
| 07/04/2001 | EP1112090A2 Method of stimulating prosaposin receptor activity |
| 07/04/2001 | EP1112082A2 Stable liquid formulations of botulinum toxin |
| 07/04/2001 | EP1112081A1 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS |
| 07/04/2001 | EP1112078A2 New use |
| 07/04/2001 | EP1007628A4 Transgenic model for heart failure |
| 07/04/2001 | EP0756708B1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation |
| 07/04/2001 | EP0736038B1 Compounds with growth hormone releasing properties |
| 07/04/2001 | EP0679187B2 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 07/04/2001 | EP0567508B1 Macroscopically oriented cell adhesion protein for wound treatment |
| 07/04/2001 | CN1302376A Corticotropin releasing factor receptor-1 deficient mice |
| 07/04/2001 | CN1302337A Method for controlling cleavage by ompT protease |
| 07/04/2001 | CN1302334A Retroviral delivery system |
| 07/04/2001 | CN1302332A Mammalian gene encoding tolloid protein |
| 07/04/2001 | CN1302330A Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 07/04/2001 | CN1302329A Method for obtaining recombinant HBsAg |
| 07/04/2001 | CN1302328A Flowering locus T(FT) and genetically modified plants having modulated flower development |
| 07/04/2001 | CN1302305A Peptides causing formation of compact structure |
| 07/04/2001 | CN1301866A Full gene cloning of horse infectious anemia virus representating virus strain and its use |
| 07/04/2001 | CN1301865A New polypeptide-plerin molybdenum oxidoreductase 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301863A New polypeptide-dihydropyridine dicarboxylic dehydrogenase 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301862A New polypeptide-xylanase or cellulase 11 and polynucleotide coding such polypeptide |